SEC Form 4 · accession 0000899243-18-029650
AVEO PHARMACEUTICALS INC · AVEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony B Evnin
Director
Period of report
Nov 21, 2018
Accepted (ET)
Nov 26, 2018 · 4:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 21, 2018 | P | 109 | $2.0499 | A | 109 | I | By Fund |
| Common Stock | holding | — | — | — | 418,414 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of shares of common stock purchased by VEF Management III, LLC, or VEFM III. Dr. Evnin is a Member of VEFM III. Dr. Evnin expressly disclaims beneficial ownership over all shares held by or on behalf of VEFM III, except to the extent of his indirect pecuniary interest therein.